<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://platform.ontopharmatech.com/monitoring</loc>
    <lastmod>2026-10-26</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/pricing</loc>
    <lastmod>2026-10-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/mcp-connect</loc>
    <lastmod>2026-10-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/privacy</loc>
    <lastmod>2026-10-26</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/terms</loc>
    <lastmod>2026-10-26</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tonight-we-ride-llc-issues-voluntary-recall-of-ultimate-forza-male-supplement-du-c5f69390</loc>
    <lastmod>2026-10-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-rare-disease-day-2027-03-05-2027-3ec28223</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-once-weekly-insulin-for-type-2-diabetes-mellitus-in-pediatric-8353b1ed</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ultra-bon-may-be-harmful-due-to-hidden-ingredient-bfd295d8</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/public-notification-green-lumber-contains-hidden-drug-ingredient-487ece1a</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-approves-deuruxolitinib-leqselvi-to-treat-severe-alopecia-areata-in-adults-bf262994</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-a-big-year-for-rnai-developers-f2a64c50</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/recently-issued-biologics-guidance-documents-0eadf605</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-approves-new-oral-treatment-for-moderate-to-severe-plaque-psoriasis-fa671c72</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/star-adds-200m-after-spinout-successes-a2f27967</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ama-and-ema-issue-joint-guidance-on-ebola-vaccine-development-7551a45a</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/protein-degrader-specialist-lycia-prices-318m-ipo-340320bb</loc>
    <lastmod>2026-10-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/natural-grocers-recalls-natural-grocers-brand-organic-2-pound-mung-beans-due-to--0b803841</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/accelerating-rare-disease-cures-arc-program-06b64a34</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/winco-foods-llc-issues-allergy-alert-on-undeclared-sesame-in-hoagie-rolls-0e412afe</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-center-for-drug-evaluation-and-research-s-arc-program-releases-its-2026-annu-1262c008</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/moderna-merck-shares-fall-on-eagerly-anticipated-cancer-vaccine-results-a68aeca8</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-traditional-approval-for-pembrolizumab-or-pembrolizumab-and-berahyalu-b88face1</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/alzheimer-s-prevention-accelerator-b8bf113c</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-launches-new-program-to-advance-neuroscience-medical-product-development-f310d56e</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/about-nain-c34eb330</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/neuroscience-advancement-and-innovation-nexus-nain-bf4b996d</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biohaven-s-previously-rejected-rare-disease-drug-to-get-fresh-fda-review-925dbf85</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/glp-1-compounder-issues-recall-for-copycat-zepbound-ab06fcb6</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/expanded-access-information-for-industry-04195555</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-affirms-sales-outlook-amid-doubts-about-its-future-127a7617</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/complex-innovative-trial-design-meeting-program-cdda000c</loc>
    <lastmod>2026-10-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-quality-center-of-excellence-discussion-series-7f657c8b</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gsk-ionis-win-us-approval-for-first-of-its-kind-hepatitis-b-drug-50f8cf4c</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roivant-continuing-ascent-claims-another-victory-for-rare-disease-drug-86d72ccb</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hormone-replacement-therapies-can-help-women-with-bothersome-menopausal-symptoms-831725f9</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/arcus-kidney-cancer-data-impresses-analysts-trigemx-inks-a-spac-deal-d0531a91</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/azurion-7-systems-eda135d8</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/i-stat-hs-tni-cartridge-cb8f09c1</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fp3d-resins-3565efc6</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/government-confirms-indefinite-recognition-of-ce-marked-medical-devices-60606f14</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medical-devices-regulations-targeted-consultation-on-the-indefinite-recognition--581abac1</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/wedgewood-pharmacy-issues-recall-of-certain-compounded-veterinary-medications-wi-394fcc8e</loc>
    <lastmod>2026-10-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-of-its-kind-chronic-hepatitis-b-treatment-c5433743</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fraudulent-products-db880adb</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rapport-s-epilepsy-drug-finds-surprising-success-in-bipolar-trial-a419c9dd</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/submitting-clinical-trial-data-to-evaluate-the-ability-to-operate-a-motor-vehicl-a44a50ea</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-pralsetinib-for-non-small-cell-lung-cancer-with-ret-gene-fusions-6a24aa72</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-once-weekly-generic-hormone-therapy-patch-for-women-9bc9aaa6</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/most-new-drugs-are-still-too-costly-at-launch-icer-says-08097e85</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/generic-drug-research-priorities-projects-33c649c8</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/engaging-with-stakeholders-to-bring-nonprescription-drug-products-to-market-20e7b006</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/signature-formulations-llc-737964-10-01-2026-76954e37</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rohto-pharmaceutical-co-ltd-733215-10-14-2026-ab2a52f6</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/zhejiang-gaorong-cosmetic-co-ltd-732511-10-01-2026-700a0b95</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/snugz-usa-inc-735284-09-28-2026-a19cc95b</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/baxter-international-inc-733231-09-29-2026-6e021adf</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-issues-final-guidance-on-prescription-drug-apps-and-software-f342e3db</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/regulatory-considerations-for-prescription-drug-use-related-software-523163c3</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/updates-to-the-prescribing-medicines-in-pregnancy-database-october-2026-bd704829</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hype-vs-reality-what-pharma-s-hottest-r-d-bets-have-actually-proved-13969c4d</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ixchiq-chikungunya-vaccine-uk-marketing-authorisation-withdrawn-following-safety-0f1b3003</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/update-import-alert-for-certain-olympus-medical-devices-manufactured-in-japan-le-128279cd</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-cardinal-health-updates-use-instructions-for-presource-packs-contain-942f0d3b</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/import-alert-for-certain-olympus-medical-devices-manufactured-in-japan-letter-to-781fa6ab</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hospital-glucose-meter-removal-nova-biomedical-removes-statstrip-glucose-hospita-0d6acc0b</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-cardinal-health-issues-correction-for-presource-packs-containing-bd--715d91f2</loc>
    <lastmod>2026-10-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-dostarlimab-for-locally-advanced-rectal-cance-94fe9d6d</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/disc-s-once-spurned-rare-disease-drug-to-get-a-second-chance-at-approval-9b2e5367</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/safety-reporting-requirements-for-inds-and-ba-be-studies-071cd3ee</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-immunotherapy-that-may-allow-certain-patients-with-rectal-cancer-to-8564410b</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-authorises-plozasiran-redemplo-for-adults-with-familial-chylomicronaemia-sy-6779dca2</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/notices-of-updates-6eaace49</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/uk-regulator-brings-new-ai-and-medtech-agenda-to-advamed-7c28aed9</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-5-to-9-october-2026-d0bd0c5c</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/merck-kgaa-bets-on-rnai-with-1-3b-silence-buyout-aacadf67</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/inactive-ingredients-database-download-88fbec92</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/quarterly-inactive-ingredient-database-iid-change-log-3b538759</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/beyond-the-lab-sahpra-introduces-nwu-students-to-careers-in-radiation-science-an-2b5214e5</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-inks-15b-adc-pact-with-hansoh-veradermics-scores-in-another-baldness-study-2caf8529</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dantrium-intravenous-dantrolene-sodium-for-injection-presence-of-particulate-mat-04ef65bc</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2026-meeting-materials-pediatric-advisory-committee-a17aa8fd</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-data-quality-framework-dqf-for-eu-medicines-regulation-application-to-coll-a621fd1f</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-12-to-16-october-2026-0a42b759</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/from-strategy-to-scale-how-saudi-arabia-is-building-a-biotech-ecosystem-b4dba918</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/extractables-in-single-use-systems-used-in-adc-manufacturing-2927145c</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-early-should-you-engage-a-cdmo-10b16a46</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/reflection-paper-on-methodological-aspects-in-confirmatory-platform-trials-ee922325</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/concept-paper-on-the-need-for-revision-of-the-guideline-on-clinical-investigatio-e15ca1b3</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/methodological-principles-for-the-assessment-of-section-5-1-of-the-summary-of-pr-f955cddf</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/diagnostic-ultrasound-system-correction-philips-ultrasound-issues-updated-use-in-5d342fc4</loc>
    <lastmod>2026-10-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/consultation-on-schools-holding-adrenaline-nasal-sprays-for-anaphylaxis-5f58fcda</loc>
    <lastmod>2026-10-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-consults-on-proposals-to-allow-schools-to-keep-spare-adrenaline-nasal-spray-569d488c</loc>
    <lastmod>2026-10-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/counterfeit-versions-of-eye-drops-found-in-several-states-b560d495</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/other-cancer-accelerated-approvals-177bb8b3</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/iambic-ceo-on-taking-an-ai-drug-company-public-d6da5246</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/what-you-should-know-about-eye-drops-b92862c2</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-27-to-31-january-2025-b953ccbc</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-new-nonprescription-eye-drop-for-relief-of-eye-redness-39e2179f</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-exclusivity-board-b12ed6bc</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-moderna-s-massive-stock-run-1d160c59</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/signa-architect-b464b039</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/architect-i-system-i2000sr-processing-module-class-4-6c04b6c2</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/nico-myriad-19x21-5-mhp-paediscope-ab03d20f</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/next-gen-rnai-drugmaker-city-prices-200m-ipo-71938e4b</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biogen-backed-estuary-nabs-93m-for-kidney-disease-gene-therapy-8c495713</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--189a6447</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/concept-paper-on-clinical-trials-in-recipients-of-kidney-transplantation-00b3314b</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lidl-us-recalls-gelatelli-coffee-vanilla-gelato-due-to-possible-health-risk-147e6421</loc>
    <lastmod>2026-10-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/10-day-forecast-may-be-harmful-due-to-hidden-ingredients-d91e48cb</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/family-farmstead-dairy-announces-recall-of-raw-mild-cheddar-cheese-due-to-potent-62502e34</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/family-farmstead-dairy-announces-recall-of-raw-mild-cheddar-cheese-due-to-potent-6522a310</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/belgian-startup-revives-galapagos-car-t-research-0e68c9f7</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-reset-continues-with-new-plan-for-reviewing-rare-disease-drugs-94b400d6</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/counterfeit-weight-loss-pens-worth-2-million-seized-by-mhra-and-west-midlands-po-c91050c3</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ema-recommends-authorisation-of-rasonque-for-metastatic-pancreatic-cancer-4a9e0301</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/outcome-of-digital-scribe-review-b2c1bdb5</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/update-to-listed-medicine-ingredients-in-october-2026-7e3f6f4a</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-reflection-paper-on-the-investigation-of-drug-interactions-of-herbal-medic-21a033b2</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/emit-2000-quinidine-assay-f89375bc</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cochlear-implant-model-ci1012-46ea43e0</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hemosil-acustar-hit-igg-pf4-h-100e9964</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-introduces-new-safeguards-to-strengthen-antidepressant-safety-information-f-36119067</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/antidepressants-new-safety-measures-for-all-patients-to-improve-communication-of-3e671bcf</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/research-antidepressants-updated-safety-communications-91e1188d</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-antidepressants-use-and-safety-9612b9f8</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-transcatheter-mitral-valve-delivery-system-issue-from-edwards-lifesc-35a8aa92</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/iambic-an-ai-drug-discovery-specialist-banks-150m-in-an-ipo-6621b5e6</loc>
    <lastmod>2026-10-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/experimental-arrowhead-rnai-drug-hints-at-alzheimer-s-benefit-53eb227f</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rare-disease-framework-bc4757ac</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-launches-the-rare-disease-framework-initiative-to-develop-a-holistic-fit-for-5441213a</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-rare-disease-framework-initiative-public-meeting-10-28-2026-57a768b9</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-an-expanded-indication-for-nogapendekin-alfa-inbakicept-pmln-for-bc-02baff55</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-treatment-for-certain-people-with-bcg-unresponsive-bladder-ca-80434508</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/verastem-cancer-drug-shows-early-promise-in-small-study-ea5d9b95</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cvs-to-pay-315m-to-settle-opioid-prescribing-allegations-70085059</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/j-j-earnings-set-negative-tone-shkreli-vs-the-ftc-a3286dc4</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/help-more-providers-prescribe-with-confidence-cdf0256c</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/primary-care-providers-can-prescribe-with-confidence-fe63bfe8</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/carelink-smartsync-device-manager-029a5180</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tracoe-experc-percut-dilation-tracheostomy-set-w-trachatraumatic-inserter-66fe5f5f</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-mhra-strategy-to-2030-what-it-means-for-you-518c668e</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-2030-strategy-to-modernise-patient-centred-regulation-for-the-era-of-ai-and-f8c5495a</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/corporate-report-mhra-strategy-2030-6aec5f4f</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-recall-avid-medical-removes-convenience-kits-affected-by-bd-chlo-6e2217cd</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/par-health-issues-voluntary-nationwide-recall-of-argatroban-injection-due-to-the-d058e1ba</loc>
    <lastmod>2026-10-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/decreasing-process-variability-in-fluid-management-systems-06a178e4</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/in-their-own-words-health-care-providers-313bfa72</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prescribe-with-confidence-fe055856</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/another-paragon-spinout-goes-public-through-reverse-merger-79e21ce0</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pan-pepin-inc-issues-allergy-alert-of-para-bien-al-grano-due-to-undeclared-sesam-2a381e54</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pan-pep-n-inc-emite-alerta-por-al-rgenos-en-el-producto-parabien-al-grano-debido-0b399866</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bsufa-ii-fiscal-years-2018-2022-a665188a</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biontech-mrna-cancer-immunotherapy-misses-first-objective-in-key-study-1f31188d</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-extends-china-deal-streak-with-1b-pact-for-rnai-obesity-drug-2816854a</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sca-pharmaceuticals-llc-724202-09-14-2026-06f9cf42</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lovelace-biomedical-research-institute-725136-10-06-2026-ebc1d543</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/john-nicole-santos-dairy-735859-10-02-2026-4cc14734</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/silgan-dispensing-systems-734538-10-05-2026-39f4c58b</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eurofins-sf-analytical-laboratories-inc-736056-10-06-2026-b4f58ced</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hanlim-pharm-co-ltd-734782-10-02-2026-2b427fbe</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/jiangmen-shuizirun-sanitary-articles-co-ltd-722974-09-23-2026-90cff3a0</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-authorises-onswik-insulin-efsitora-alfa-for-adults-with-type-2-diabetes-4e4faaf1</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/list-of-drug-master-files-dmfs-7140a768</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/continuous-renal-replacement-therapy-crrt-consider-delayed-administration-of-con-d3d6f573</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-recall-medline-removes-convenience-kits-affected-by-bd-chlorapre-f265038f</loc>
    <lastmod>2026-10-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/first-tracks-climbs-on-impressive-celiac-study-data-f2cc4425</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/first-tracks-climbs-on-impressive-celiac-study-data-5c839304</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/parkinson-s-cell-therapy-developer-files-to-go-public-f18c5a79</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bristol-myers-dips-on-confounding-lung-drug-results-b9a1c643</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hiding-in-plain-sight-7-oh-products-4e5b2e2d</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pharma-s-500b-patent-problem-will-come-in-waves-not-as-a-cliff-84de6704</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bausch-lomb-swaps-ceos-merck-reveals-anticipated-eye-drug-data-3d7a9b48</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-2-medicines-recall-norgine-pharmaceuticals-limited-pedmarqsi-80-mg-ml-solu-637eab5c</loc>
    <lastmod>2026-10-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ventilator-recall-coopersurgical-removes-inca-infant-nasal-cpap-sets-ee22fe9e</loc>
    <lastmod>2026-10-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/oliva-llc-issues-allergy-alert-on-undeclared-sesame-in-baba-ghanouj-spicy-baba-g-0f462285</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/krasnyi-oktyabr-inc-recalls-starfish-seafood-trio-because-of-possible-health-ris-0c70bd8a</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/krasnyi-oktyabr-inc-recalls-starfish-seafood-premium-cold-smoked-norwegian-salmo-e7716e5b</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/phase-1-ind-frequently-asked-questions-33146141</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-drug-to-treat-lesions-caused-by-herpes-simplex-virus-09993709</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/nova-biomedical-statstrip-ketone-test-strips-risk-of-disruption-to-blood-ketone--f3e95052</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-for-october-2026-155302ae</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-review-docs-spark-revolution-sell-off-zealand-diabetes-data-underwhelm-analy-22148fc3</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-what-s-driving-biotech-s-recent-pullback-e28e8455</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/annual-report-of-the-pharmacovigilance-inspectors-working-group-for-2025-41a6fb15</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/questions-and-answers-on-the-pip-compliance-verification-procedure-at-ema-and-on-01013f31</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/questions-and-answers-on-the-pip-compliance-verification-procedure-at-ema-and-on-f92a5192</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-6-8-74e671b0</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/questions-and-answers-on-biosimilar-development-and-the-bpci-act-56873535</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/postapproval-manufacturing-changes-to-biosimilar-and-interchangeable-biosimilar--f0565a8a</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-mhra-real-world-evidence-knowledge-and-guidance-ebc6ef8e</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/trex-bio-prices-117m-ipo-to-support-immune-drug-work-a5cc5ede</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-28-september-2026-to-2-october-2026-7f596672</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/research-role-of-the-digital-mental-health-technology-dmht-working-group-654ffd91</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/research-patient-reported-outcomes-pros-resources-for-digital-mental-health-tech-859df5bd</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-chair-professor-anthony-harnden-bringing-our-strategy-to-life-listening-lea-0f9402fb</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/par-health-issues-voluntary-nationwide-recall-of-two-lots-of-brevital-sodium-500-94f6542e</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-diagnostic-ultrasound-system-issue-from-philips-ultrasound-46d2d5b7</loc>
    <lastmod>2026-10-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gardeners-basics-recalls-waltham-29-broccoli-sprouting-seeds-due-to-possible-sal-47b4ffa0</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hhs-launches-new-plan-to-strengthen-vaccine-injury-research-reporting-98972665</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/study-data-technical-conformance-guide-technical-specifications-document-b2ebfc8d</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-pediatric-safety-communications-b66b7e37</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-atezolizumab-in-combination-with-chemotherapy-for-stage-iii-mismatc-6e32a48d</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/viatris-boosts-pain-drug-portfolio-with-1-7b-buyout-of-pacira-c572b1b1</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/argenx-falls-as-sj-gren-s-setback-offsets-celiac-drug-progress-18cc0acf</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/in-the-hunt-for-reverse-merger-targets-caribou-could-be-prized-game-96f660d7</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/haleon-issues-voluntary-nationwide-recall-of-robitussin-honey-cf-max-day-adult-a-6edd7570</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/clinical-trial-applications-advice-pilot-becomes-permanent-6424e79d</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-the-requirements-for-demonstrating-therapeutic-equivalence-fo-e1c99458</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-pneumococcal-vaccine-factsheet-information-for-patients-parents-and-car-aa7d96de</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/requirements-and-resources-for-approved-andas-b3808f8c</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/freeo2-automated-oxygen-therapy-device-adult-pediatric-version-hw-2-3-683af8b4</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/trusystem-7000-and-trusystem-7500-surgical-tables-9b5e3e35</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cardinal-health-presource-kits-8dfbd1c4</loc>
    <lastmod>2026-10-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eden-brothers-recalls-calabrese-broccoli-seeds-due-to-possible-salmonella-contam-bb47cd04</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-an-20a136d4</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-tucatinib-with-trastuzumab-and-pertuzumab-for-the-maintenance-treat-030e5ef4</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/caribou-to-halt-car-t-work-lay-off-staff-amid-challenging-funding-climate-02941ced</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/halozyme-prevails-in-patent-fight-with-merck-enliven-readies-anticipated-leukemi-cb89c5d7</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-approves-catumaxomab-to-treat-cancer-related-fluid-build-up-in-the-abdomen-8bbcfe90</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-takeda-spinout-builds-case-for-its-parkinson-s-drug-78b34536</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/perma-sharp-sutures-061d1906</loc>
    <lastmod>2026-10-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/forbion-a-prominent-biotech-investor-raises-2-6b-for-a-pair-of-venture-funds-d882ea7f</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pacific-health-sciences-voluntarily-recalls-one-lot-of-babies-magic-tea-brand-ba-3762ad2c</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/arrivent-collapses-on-disappointing-lung-cancer-data-6896821e</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dual-acting-drug-from-abbvie-genmab-scores-in-frontline-lymphoma-trial-2780188e</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/concept-paper-on-the-guideline-revision-on-good-pharmacogenomic-practice-8387b504</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/leader-formulas-llc-issues-voluntary-nationwide-recall-of-rapture-preworkout-due-b39881f3</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/organicare-llc-organicare-nature-s-science-llc-734925-10-01-2026-0bf368aa</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/amazon-com-inc-736006-10-01-2026-5ed8193e</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roycederm-llc-734781-10-01-2026-a90f168b</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bioactive-services-usa-llc-herstat-inc-734784-10-01-2026-5474d3a0</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/terramed-735070-10-01-2026-72af4d92</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/desbio-deseret-biologicals-inc-735464-10-01-2026-547a49e3</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/graceful-touch-llc-735272-10-01-2026-0fc4168d</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-platinum-healthcare-llc-735147-10-01-2026-4eb1d7c0</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/walmart-inc-736557-10-01-2026-832cbdfa</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/aidance-scientific-inc-735346-10-01-2026-a557dd6d</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pine-pharmaceuticals-llc-728537-08-07-2026-2f3ee85e</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cheap-medicine-shop-www-cheapmedicineshop-com-737810-09-24-2026-284d70ed</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tci-co-ltd-biocosme-pabp-branch-736888-09-02-2026-8d0560d5</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/online-generic-medicine-www-onlinegenericmedicine-com-737806-09-23-2026-619eccaf</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/carvedilol-25-mg-tablets-out-of-specification-impurity-f577fde6</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pms-carvedilol-25-mg-tablets-out-of-specification-impurity-63789a07</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fluoroplastic-vent-tube-cc138644</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cardinal-health-general-procedure-tray-ae540299</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/embletta-mpr-pg-f07fb2f5</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-top-biopharma-conferences-in-2027-b14f94ca</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ge-healthcare-to-acquire-sofie-biosciences-for-945m-c8ce410c</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/government-backs-recommendations-of-nhs-doctors-led-ai-commission-8655ef98</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/nova-biomedical-announces-global-medical-device-correction-for-statstrip-glucose-ca1cdf11</loc>
    <lastmod>2026-10-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-what-the-national-commission-s-recommendations-mean-for-you-f2aa38f4</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-ai-airlock-phase-3-application-93f0b6b2</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/policy-paper-government-response-to-the-national-commission-s-recommendations-on-6e3d6234</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/expedited-investigational-new-drug-pilot-program-application-instructions-88b8ef12</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-quantitative-medicine-center-of-excellence-qm-coe-1ba1feac</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/m15-resource-center-02318dc7</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/glenmark-pharmaceuticals-limited-637314-09-23-2026-a13fa759</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/glenmark-pharmaceuticals-limited-637314-11-22-2022-f1fdb26b</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/shionogi-pays-2b-to-acquire-a-rare-disease-startup-f6c96b25</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-good-machine-learning-practice-for-medical-device-development-94e8671f</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/optogenics-researchers-win-a-nobel-prize-roche-bets-on-alector-brain-drug-661aab5f</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/vaxcyte-skyrockets-on-near-best-case-pneumococcal-vaccine-data-3c20a63e</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/psychedelic-drugs-af39aabb</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-seeks-public-input-to-support-ibogaine-research-5a3d8da8</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/advisory-committees-give-fda-critical-advice-and-the-public-a-voice-61a5b2fd</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lumify-ultrasound-system-557ba7d7</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-3-medicines-recall-norgine-limited-movicol-plain-13-7g-powder-for-oral-sol-76e70bb7</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/precision-for-all-closing-the-gap-between-innovation-and-impact-994f8f3d</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-ai-is-transforming-biopharma-manufacturing-facilities-of-the-future-8da2f1c3</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/iv-tubing-set-correction-icu-medical-updates-use-instructions-for-iv-tubing-sets-59a8a695</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/infusion-set-recall-bd-and-carefusion-303-inc-remove-bd-alaris-pump-infusion-set-fc9d10e5</loc>
    <lastmod>2026-10-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/stewart-s-shop-corp-recalls-heavenly-medley-and-vanilla-chocolate-strawberry-due-badc0fac</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eak-distribution-llc-recalls-home-grown-green-sprouting-calabrese-broccoli-seeds-b197681e</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-pirtobrutinib-for-previously-untreated-chronic-lymphocytic-leukemia-62941982</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/frutas-y-hortalizas-del-sur-s-a-expands-recalls-to-include-additional-lots-of-gr-4442c801</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/transparency-makes-modern-regulatory-science-stronger-fda-s-transparency-roadmap-53402e59</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/flowers-foods-issues-recall-of-nature-s-own-hawaiian-bread-due-to-undeclared-mil-604a8134</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-kodiak-s-big-comeback-and-hengrui-s-dealmaking-8329faac</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-wagers-almost-8b-on-a-chinese-biotech-s-rna-drugs-6a6a3549</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/webinar-for-stakeholder-engagement-on-the-new-final-guideline-on-general-princip-d0b1455b</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/automated-impella-controllers-aic-dceb3911</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hcg-cassettes-52b1cbbd</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hcg-one-step-pregnancy-tests-2c88a946</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-28--b6aebb6c</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/renewing-marketing-authorisations-for-medicines-c929089f</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/apply-for-a-licence-to-market-a-medicine-in-the-uk-851fd6ac</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/electronic-application-forms-eaf-for-uk-medicines-licensing-applications-de33d6e5</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/decision-advertising-investigations-september-2026-813e8cc1</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/important-notice-on-cybersecurity-threats-f69afd1b</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/breathing-circuit-recall-draeger-removes-ventstar-resus-neo-hoses-25ec6178</loc>
    <lastmod>2026-10-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/winco-foods-of-boise-id-is-recalling-the-following-salsa-bean-dip-trays-due-to-t-d7088b5b</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cheminformatics-resources-of-u-s-governmental-organizations-2027-workshop-04-12--d749fdeb</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-heart-valve-designed-to-grow-with-children-952d5c96</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-center-for-clinical-trial-innovation-c3ti-b910c418</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/c3ti-demonstration-program-frequently-asked-questions-faqs-fe925d06</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/3-takeaways-from-a-european-obesity-scientific-meeting-14a03b8c</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lilly-foghorn-part-ways-wave-s-fda-approved-plans-154f5a27</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/facilitating-collaboration-across-cder-a5c441d3</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sanofi-regeneron-broaden-alliance-to-find-their-next-dupixent-376b924e</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/clinical-trials-day-6f9b6d5c</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/what-s-new-in-clinical-trial-innovation-6d88b498</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hhs-kicks-off-new-programs-to-speed-clinical-trials-as-chinese-competition-looms-543c1081</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-joins-global-regulators-in-call-to-advance-alternatives-to-animal-testing-f951dc00</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pfizer-s-eczema-drug-clears-skin-in-mid-stage-trial-1cbd5e8d</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/office-of-generic-drugs-offices-and-divisions-03c108fd</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/advice-on-end-of-year-submission-dates-for-type-i-variations-in-2026-06c280ac</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ema-management-board-highlights-of-september-2026-meeting-db16ce45</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rare-diseases-team-d0051a86</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/importing-human-drugs-a17719e7</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-neuraxpharm-uk-limited-levetiracetam-neura-b32452a2</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medline-sterile-surgical-kits-containing-medline-c-section-drape-w-incise-bb919bd3</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/carelink-smartsync-device-manager-67e49d96</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/global-regulators-call-for-advancing-alternatives-to-animal-testing-across-the-m-2a56db89</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/executive-director-speech-at-ema-women-s-health-multi-stakeholder-workshop-a63226b8</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-program-for-the-recognition-of-voluntary-consensus-standards-related-to-pha-5f4b3d30</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-drug-info-rounds-video-d76588d6</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-safety-related-labeling-changes-srlc-database-overview-updates-to-safety-in-a09126d4</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-to-request-domperidone-for-expanded-access-use-380038df</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-bad-ad-program-fb6a424e</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-safety-information-c06e73b7</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-contact-information-2b960a0a</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidances-drugs-133b486e</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/regulatory-pharmaceutical-fellowship-program-0cbdccd1</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-documents-office-of-drug-information-638bb905</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-interactions-relevant-regulatory-guidance-and-policy-documents-827026c4</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/frequently-asked-questions-about-drugs-753c9bfc</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-cder-reference-guide-eba4b988</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/greenwich-rx-issues-voluntary-nationwide-recall-of-compounded-glutathione-due-to-cc5d6a88</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gias-foods-inc-recalls-bettergoods-authentic-italian-lemon-alfredo-fettuccine-be-2add0b77</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/saint-francis-apizza-llc-issues-a-voluntary-recall-of-its-frozen-pizzas-for-miss-6e151584</loc>
    <lastmod>2026-10-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-adverse-event-monitoring-system-aems-electronic-submissions-8de09302</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-adverse-event-monitoring-system-aems-e2b-r3-data-standards-9b7dd217</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bristol-myers-trial-revisions-shake-confidence-in-new-class-of-fibrosis-drugs-ab3e85cb</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-starts-review-of-roche-s-multiple-sclerosis-pill-2817c01a</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dia-and-mhra-announce-speaker-line-up-for-inaugural-global-summit-b6d22d8f</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-14-day-assessment-stepwise-implementation-programme-for-phase-1-clinica-6c36cf20</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/phrma-names-next-ceo-pierre-fabre-takes-third-swing-at-ebvallo-approval-b83805ef</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-launches-nationwide-effort-to-expand-scientific-expertise-and-consumer-voice-b7e1c407</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/women-are-missing-from-medicines-development-ema-s-roadmap-for-change-b490ef49</loc>
    <lastmod>2026-09-30</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-investigation-leads-to-charges-against-two-indian-nationals-involved-in-tran-da4d5e2a</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-center-for-research-on-complex-generics-crcg-workshop-on-long-acting-injecta-43a7b061</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/beam-sues-2-biotechs-alleging-theft-of-base-editing-trade-secrets-d0bb9f2f</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/study-data-standards-resources-45ce0d62</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-the-centres-of-excellence-for-regulatory-science-and-innovation-program-76880fe1</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novo-to-pay-hengrui-up-to-2-6b-for-a-once-weekly-obesity-pill-ad2e264c</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/uniqure-tumbles-with-latest-data-for-huntington-s-gene-therapy-f72334bc</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-21-to-25-september-2026-8b0c2ab6</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/supporting-clinical-practice-guidelines-for-drugs-with-abuse-potential-446c3a6d</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/listed-medicine-compliance-reports-september-2026-update-857f74c9</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sciarra-aeromed-inc-728248-09-23-2026-414dcb1c</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/neogen-corporation-731018-09-23-2026-7b6b3f50</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/veganicskn-limited-719883-02-09-2026-f3d2c0f6</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/wilson-livestock-728168-07-24-2026-17db21c4</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/curia-new-york-inc-728790-09-18-2026-f73dd371</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kellin-chemicals-co-ltd-716228-zhangjiagang-419fa74e</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/stream2sea-llc-718983-02-02-2026-c1f85251</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bentley-laboratories-llc-732028-09-17-2026-d8eb0018</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/celmade-735876-09-14-2026-2e9f4d70</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fresenius-kabi-ag-733107-09-22-2026-1690e24a</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-safety-roundup-september-2026-6766b22f</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ai3bio-built-from-two-biotechs-pursues-a-different-path-to-an-immune-reset-d35b0ee4</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/astrazeneca-invests-2b-in-summit-gaining-seat-at-the-table-for-pd-1-vegf-drug-pu-90ed52ae</loc>
    <lastmod>2026-09-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-treatment-for-mct8-deficiency-074cf261</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-intends-to-evaluate-changes-to-the-pmta-regulatory-framework-5604b39d</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/boothwyn-pharmacy-llc-717525-01-16-2026-5cce3ff8</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gdufa-paid-facilities-list-8b91e434</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kodiak-skyrockets-on-positive-study-data-for-2-eye-drugs-21091f05</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/an-off-the-shelf-car-t-therapy-from-adicet-shows-promise-against-lupus-53a8885a</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sierra-nevada-cheese-company-recalls-graziers-raw-milk-cheese-because-of-possibl-305ca9a6</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-medicine-labelling-standards-55160f27</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tga-releases-new-guidance-to-explain-when-news-content-may-be-advertising-30d609f5</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/improvements-to-monthly-product-information-updates-608b8e0b</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/merck-daiichi-end-plans-to-seek-speedy-approval-of-lung-cancer-adc-a5aec7ec</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pms-fampridine-10-mg-tablet-affected-lot-may-contain-foreign-material-particles-94b40d9e</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bd-alaris-pump-module-and-subset-of-compatible-pump-infusion-sets-dc602a85</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/breakthrough-therapies-still-need-builders-8450580e</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kids-shouldn-t-have-to-organize-childhood-around-medicine-4d8927ac</loc>
    <lastmod>2026-09-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/candy-power-for-man-may-be-harmful-due-to-hidden-ingredient-c2f70ce7</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/miracle-power-of-king-kong-honey-may-be-harmful-due-to-hidden-ingredient-a8e83894</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/public-notification-vital-honey-contains-hidden-drug-ingredient-99a48f37</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-third-treatment-for-fibrodysplasia-ossificans-progressiva-dad49eee</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/q-a-with-fda-podcast-859b0060</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-drug-to-treat-idiopathic-nephrotic-syndrome-in-patients-2-years-and-198cfde8</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2019-meeting-materials-dermatologic-and-ophthalmic-drugs-advisory-committee-c937171a</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2026-meeting-materials-dermatologic-and-ophthalmic-drugs-advisory-committee-0ba85b6c</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/critical-path-innovation-meeting-cpim-topics-held-to-date-7890905a</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-novo-s-rise-and-fall-and-ai-biotechs-big-haul-67d63c49</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/october-30-2026-dermatologic-and-ophthalmic-drugs-advisory-committee-meeting-ann-4753bc35</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novo-pursues-long-acting-obesity-drugs-acadia-slumps-on-alzheimer-s-data-76c93154</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sanofi-aventis-canada-inc-recalling-certain-insulin-pens-and-cartridges-18701212</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/limited-number-of-sarclisa-single-use-vials-may-have-been-frozen-during-shipment-bee98a8f</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/amplatzer-amulet-left-atrial-appendage-occluder-39a28ee6</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/perma-hand-silk-suture-0a32aab9</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tex-stein-dairy-728755-06-16-2026-84c36af8</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fairygene-inc-726976-07-31-2026-6261f1dc</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lico-industries-llc-d-b-a-american-towelette-company-729921-07-30-2026-c319d0f1</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/angiographic-catheter-recall-boston-scientific-removes-imager-ii-angiographic-ca-adee1685</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rnai-drug-specialist-adarx-raises-446m-ipo-b0a45ade</loc>
    <lastmod>2026-09-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/grail-multicancer-detection-test-wins-fda-advisers-backing-cdc741d8</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/deano-s-pasta-issue-allergy-alert-on-undeclared-lobster-in-pear-and-pecorino-tri-5abce9b5</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-nominee-overton-parries-vaccine-questions-at-senate-hearing-8b3fd6b4</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/galil-importing-corp-recalls-lior-cinnamon-ground-seasoning-due-to-elevated-lead-c044957e</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-belzutifan-in-combination-with-lenvatinib-for-advanced-renal-cell-c-b6370c54</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/zenzi-pharmaceutical-industries-private-limited-701130-09-18-2026-b5103f19</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/zenzi-pharmaceutical-industries-pvt-ltd-701130-02-13-2025-7e1f6bd1</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-supply-chain-security-act-dscsa-assessment-of-small-dispensers-eb751f20</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/merck-reveals-study-success-and-possible-safety-worries-for-eye-drug-hopeful-3564ac70</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lilly-s-latest-china-drug-deal-immunovant-s-setback-in-lupus-a1f3a45d</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/professor-dame-anna-dominiczak-professor-alison-strath-and-fiona-cohrane-catalys-ec9f9c49</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-once-weekly-insulin-for-type-2-diabetes-mellitus-76daea6b</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/five-new-commissioners-appointed-to-the-commission-on-human-medicines-chm-66bad22a</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/inzone-detachment-system-d59480e4</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/likorall-patient-lift-systems-9dc6d7aa</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/interstim-systems-973a5ebe</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-welcomes-sentencing-after-fraud-convictions-over-falsely-certified-medical--5a49f5ef</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/member-states-contact-points-for-review-of-national-implementation-of-quick-resp-d9da8482</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ins-gcp-1-procedure-for-coordinating-good-clinical-practice-inspections-requeste-d7abe330</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ins-gcp-1-procedure-for-coordinating-good-clinical-practice-inspections-requeste-6fc70350</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-the-clinical-requirements-for-medicines-intended-for-the-trea-7dfcf427</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-the-clinical-requirements-for-medicines-intended-for-the-trea-bfa319de</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/heart-pump-controller-recall-abiomed-removes-automated-impella-controllers-a695ce19</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-correction-becton-dickinson-issues-correction-for-kits-and-proce-ac167619</loc>
    <lastmod>2026-09-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/g-l-mezzetta-inc-announces-recall-of-mezzetta-brand-golden-greek-peperoncini-med-77c9bd40</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/berlin-seeds-recalls-alfalfa-sprouting-seed-because-of-possible-health-risk-52bff207</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/federal-court-enters-consent-decree-against-gold-star-distribution-inc-following-3ab3aa53</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-lirafugratinib-for-previously-treated-unresectable-locally-advanced-09f0d2f0</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/enveda-an-ai-drugmaker-banks-311m-in-venture-funding-fca3b123</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/public-meeting-on-patient-focused-drug-development-for-long-covid-04-25-2023-3b46749d</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-ionis-rna-drug-scores-in-kidney-disease-study-84f66da6</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-approves-lurbinectedin-for-adults-with-extensive-stage-small-cell-lung-canc-aa1c8f1a</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/9-pharma-leaders-sound-alarm-bells-on-biotech-s-decline-in-europe-77ea97eb</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-b-braun-melsungen-ag-meropenem-1000-mg-pow-577c8a5c</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/williams-cystoscopic-injection-needle-95868999</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/omniasecure-mri-surescan-e66e99b6</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-14-to-18-september-2026-836d916a</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/substances-considered-as-not-falling-within-the-scope-of-regulation-ec-no-470-20-b19a804c</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-ventilator-issue-from-react-health-8c2b69f1</loc>
    <lastmod>2026-09-23</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/amgen-reports-a-phase-3-win-with-sj-gren-s-drug-candidate-bca889db</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/viking-shares-surge-on-updated-obesity-drug-data-aad7d2b3</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/celldex-sinks-as-safety-concerns-cloud-immune-drug-results-1a266947</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/innovative-science-and-technology-approaches-for-new-drugs-istand-program-0c240868</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/an-orexin-drug-s-proof-of-concept-in-adhd-cue-s-unwarranted-share-slide-df758c7e</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-accepts-wearable-sensor-derived-foot-drop-metrics-under-istand-as-longitudin-74cb471b</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tga-business-services-beta-release-november-2025-to-february-2026-4956ae9a</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/empower-clinic-services-llc-dba-empower-pharmacy-738238-09-18-2026-07ded74d</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kdc-one-chatsworth-inc-733205-09-08-2026-dec8903a</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/impact-stories-8dee305b</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-novel-stratum-specific-trial-design-improves-statistical-power-for-rare-diseas-b486730c</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/proteomics-based-biomarker-discovery-a-systematic-framework-to-address-regulator-a65596e1</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/comparative-clinical-studies-for-assessing-the-safety-and-immunogenicity-of-bios-7e5a39fc</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-hidden-tradeoff-in-trump-s-drug-pricing-deals-61788bdc</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/beyond-admet-ai-for-medicines-safety-survey-fecbc22b</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/funding-opportunity-launched-to-strengthen-uk-regulatory-science-and-support-hea-c8b5e6fd</loc>
    <lastmod>2026-09-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/acetaminophen-bd882208</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/global-mix-inc-recalls-niwali-tejocote-capsules-and-niwali-tejocote-pieces-becau-ca8c8f00</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/beacon-eye-gene-therapy-hits-mark-in-late-stage-study-f985fe8c</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novo-talks-up-drug-launches-in-effort-to-win-back-investors-5b19a86d</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-updates-regulations-to-advance-innovative-alternatives-to-animal-testing-3225684d</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-roundup-june-18-2024-57c9df05</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-roundup-july-26-2024-bc277881</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/imaavy-affected-lots-may-contain-glass-particles-6e3547d5</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/telix-buys-itm-in-bid-to-create-a-radiopharmaceutical-powerhouse-142d6567</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-j-j-paved-the-way-for-compass-coming-psychedelic-drug-launch-ea8b8181</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/report-on-the-international-active-pharmaceutical-ingredient-inspection-programm-d87d268c</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/are-healthcare-systems-really-ready-for-glp-1s-8ce26ed6</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/behind-the-outcomes-how-whole-patient-support-is-reshaping-oncology-care-715899fb</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ich-m13b-guideline-on-bioequivalence-for-immediate-release-solid-oral-dosage-for-f75c5517</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/par-health-issues-voluntary-nationwide-recall-of-two-lots-of-dexmedetomidine-hcl-1ab7c8de</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-of-0-9-sodium-chloride-98f7050d</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-correction-avid-medical-issues-correction-for-kits-containing-hu-ffd8a7a2</loc>
    <lastmod>2026-09-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/andrographis-removed-from-listed-medicines-framework-because-of-allergy-risk-aab3e572</loc>
    <lastmod>2026-09-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-g-a-n-g-s-t--87297e32</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-imlunestrant-in-combination-with-abemaciclib-for-er-positive-her2-n-b189843d</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sahpra-reinforces-its-commitment-to-radiation-safety-at-iaea-general-conference-e23b9472</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/chemistry-manufacturing-and-controls-development-and-readiness-pilot-cdrp-progra-49838307</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/project-orbis-4ce80082</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-therapy-to-treat-ataxia-in-patients-with-ataxia-telangiectasia-a-ra-45905a3c</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/xenon-shares-fall-following-depression-trial-pause-71e97287</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-gsk-s-china-deals-the-300m-ipo-club-and-selling-the-news-c38a0bb5</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ultragenyx-prices-sanfilippo-gene-therapy-at-4m-bristol-myers-shelves-orum-drug-91f07938</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-streamlined-nonclinical-studies-and-acceptable-new-approach-methodologies-n-41189b47</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-approach-methodologies-nams-database-of-use-case-examples-4de7aa49</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-user-safety-for-pharmaceutical-veterinary-medicinal-products--9d060386</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/counterfeit-laser-hair-removal-and-therapy-devices-found-in-some-clinics-and-may-a38c0c05</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/signa-artist-and-signa-artist-evo-db6df67b</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-user-safety-of-topically-administered-veterinary-medicinal-pr-04950eec</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--82f3887b</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-veterinary-good-pharmacovigilance-practices-vgvp-module-signa-fdd40b30</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-reflection-paper-on-the-clinical-investigation-of-medicinal-products-for-t-f3c6b015</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/questions-and-answers-on-post-approval-change-management-protocols-for-veterinar-ad5f3aff</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-cvmp-guideline-on-the-summary-of-product-ch-606f28cc</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sodium-chloride-flush-recall-spectra-medical-removes-sodium-chloride-injection-u-0764a3e5</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/nitric-oxide-delivery-system-correction-noxbox-updates-use-instructions-for-noxb-72197d83</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/electra-amasses-350m-in-biotech-s-latest-big-ipo-ef93f50d</loc>
    <lastmod>2026-09-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lisata-deal-propels-marea-s-drug-pipeline-to-wall-street-0cb702ed</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/animal-rule-information-60753cc3</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-gene-therapy-for-pediatric-patients-with-sanfilippo-syndrome--9a028a53</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/korea-filler-experts-718706-11-03-2025-3088beb5</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novo-partners-with-orbis-deepening-investment-in-oral-peptide-drugs-19f00c15</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-public-workshop-future-needs-for-the-development-of-interchangeable-products-1d8e39c5</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/north-immunology-joins-biotech-reverse-merger-boom-with-aethlon-deal-7f434f29</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-safety-oversight-board-dsb-meeting-june-26-2024-38afe13a</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/human-drug-compounding-39ebb787</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/radiofrequency-rf-safety-considerations-for-wireless-cardiotocography-ctg-monito-3caf0303</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rapicide-pa-high-level-disinfectant-0bf05a7a</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/trinity-biotech-oxalate-reagent-kit-c362a576</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/philips-ingenia-achieva-and-intera-mr-systems-059fbfa3</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-martindale-pharmaceuticals-ltd-clobazam-ma-63d91c4e</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-dualitas-team-up-to-find-bispecific-drugs-for-immune-diseases-a20e3e70</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-to-pay-125m-for-blood-brain-barrier-crossing-platform-c28c7392</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/verified-clinical-benefit-cancer-accelerated-approvals-cc6aa8d1</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-clarifies-policies-for-compounders-as-national-glp-1-supply-begins-to-stabil-444a194a</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/reporting-prescription-drug-sample-losses-known-thefts-and-possible-diversion-in-d0b2c040</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/center-for-drug-evaluation-and-research-organization-chart-07165cb3</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/saratoga-potato-chips-issues-allergy-alert-on-undeclared-soy-in-j-higgs-loaded-b-0f9a13f1</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novo-looks-to-anthropic-s-ai-models-to-supercharge-drug-development-d81659eb</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/resources-for-information-approved-drugs-95008404</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sling-banks-123m-for-an-experimental-thyroid-eye-disease-pill-d49237bb</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pre-submission-advice-support-for-innovative-medicines-b759ee51</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/national-assessment-procedure-for-medicines-6b1f1a37</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/skyhawk-racks-up-more-support-for-huntington-s-drug-3db6bb8d</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/investigational-new-drug-application-ind-170e6a71</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-sets-out-steps-to-prevent-avoidable-harm-from-patient-hoists-26c8f7e6</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/intellispace-critical-care-and-anesthesia-0e154619</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ndi-passive-spheres-6c178c2a</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/platinum-naturals-easymulti-stress-men-affected-lots-incorrectly-labelled-for-vi-a8074bfc</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-national-patient-safety-alert-supporting-information-patient-hoists-and-c597f0ed</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/national-patient-safety-alert-patient-hoists-and-slings-all-types-risk-of-death--b381a57f</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-good-clinical-practice-inspections-31e3f806</loc>
    <lastmod>2026-09-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-clears-first-generic-radioligand-drug-sionna-turns-to-layoffs-e37edf15</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/deep-may-be-harmful-due-to-hidden-ingredient-133415ed</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/beauty-911-may-be-harmful-due-to-hidden-ingredient-034ed936</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/luze-fit-intensity-may-be-harmful-due-to-hidden-ingredient-313ba357</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/so-delicious-dairy-free-issues-voluntary-recall-of-salted-caramel-cluster-non-da-94c341b1</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/information-for-placed-students-dbfb568d</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/about-fda-psep-74f6b77a</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-to-apply-91ba6e0e</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-pharmacy-student-experiential-program-da91feb1</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-s-drug-registration-and-listing-workshop-compliance-regulatory-and-submissio-f5ec8251</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gias-foods-inc-recalls-bettergoods-authentic-italian-lemon-alfredo-fettuccine-be-2d917b52</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-additional-information-in-labeling-for-kybella-deoxycholic-acid-inj-1a036b56</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/wclc-26-a-new-adc-era-china-questions-and-astrazeneca-s-spotlight-e00e8263</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-expedited-investigational-new-drug-ind-pilot-program-7e118e52</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/an-america-first-approach-to-medical-innovation-56dd74e3</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-launches-pilot-program-to-speed-up-early-us-drug-research-a10865b0</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-launches-expedited-ind-pilot-begins-accepting-applications-79ae3b82</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/expedited-ind-rolling-submission-process-and-program-structure-cd5c09d0</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/organika-gummies-foreign-site-not-listed-on-site-licence-4555afa2</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-and-malaysia-strengthen-partnership-on-healthcare-innovation-and-research-fca968da</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/esophageal-ph-monitoring-capsule-recall-medtronic-and-given-imaging-remove-esoph-a1071ddc</loc>
    <lastmod>2026-09-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/summit-akeso-look-to-shed-pd-1-vegf-drug-doubts-with-latest-study-results-a03b7f06</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-p-creations-llc-issues-nationwide-recall-of-biq-fel-due-to-undeclared-sildenaf-91183391</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2026-dia-fda-oligonucleotide-based-therapeutics-conference-09-23-2026-6acb7b5f</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-p-creations-llc-issues-nationwide-recall-of-x10-natural-enhancement-supplement-08888261</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/astrazeneca-s-newly-approved-pill-fails-frontline-breast-cancer-study-a5249c35</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/send-and-receive-information-on-adverse-drug-reactions-adrs-599cb92a</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rise-to-the-challenge-statistical-considerations-for-rare-disease-clinical-inves-3ad298c2</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cellectis-quits-car-t-and-pivots-to-in-vivo-gene-editing-cf04bdd5</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ocmo-guidance-agenda-13187134</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pain-and-arthritis-products-containing-hidden-ingredients-abd1a8e1</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/qu-feng-huo-luo-dan-may-be-harmful-due-to-hidden-ingredient-ef70f36b</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/industry-frequently-asked-questions-95b566c1</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sahpra-and-lesotho-strengthen-regional-collaboration-for-regulatory-excellence-1aeac498</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/scholar-rock-sma-drug-approved-by-fda-fa6adb8b</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/international-collaboration-on-gmp-inspections-93c8322f</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/report-on-the-international-active-pharmaceutical-ingredient-inspection-programm-9f3b0521</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tzield-teplizumab-and-the-risk-of-viral-reactivation-874c4ce5</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-7-september-to-11-september-2026-27cdf741</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/centric-compounding-issues-nationwide-recall-of-glutathione-myer-s-cocktail-and--578a1707</loc>
    <lastmod>2026-09-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/whole-foods-market-issues-allergy-alert-on-undeclared-egg-in-cabricharme-cheese-bdd70c1b</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-therapy-to-target-muscle-loss-in-spinal-muscular-atrophy-ffbbf9e9</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eco-nams-webinar-series-qsars-to-predict-aquatic-toxicity-09-17-2026-48516a28</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-treatment-for-children-aged-4-11-years-with-apds-a-rare-genet-781361fc</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-ra-s-insatiable-appetite-novartis-big-slide-and-a-reverse-me-d75f18b5</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/advanced-therapy-medicinal-products-regulation-and-licensing-in-uk-4936dddc</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/karyopharm-pushes-off-debt-payment-amgen-eyes-broader-imdelltra-use-25c4db99</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mrna-cancer-vaccines-biggest-barriers-to-market-74edf0c0</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-8-1-31bdf490</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-the-investigation-of-interactions-in-the-gastrointestinal-tra-a22209d7</loc>
    <lastmod>2026-09-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/evergreen-fresh-sprouts-llc-recalls-broccoli-sprouts-because-of-possible-health--f6f452d2</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tips-to-stay-safe-in-the-sun-from-sunscreen-to-sunglasses-6f00dd96</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/should-you-put-sunscreen-on-infants-not-usually-9ed1af32</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-rare-disease-innovation-hub-cecfa63c</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/jobs-in-oncology-hematology-3eef77be</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-places-partial-hold-on-biohaven-s-epilepsy-drug-81f64035</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/andy-plump-architect-of-takeda-s-r-d-overhaul-to-retire-next-year-bc7ef15c</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/questions-and-answers-fda-s-regulatory-actions-on-over-the-counter-sunscreen-153d70fe</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sunscreen-how-to-help-protect-your-skin-from-the-sun-cf640276</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-quality-center-of-excellence-annual-conference-a7ae1e64</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2027-compounding-quality-center-of-excellence-annual-conference-03-11-2027-aa275d51</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/generic-acetaminophen-by-teva-recalled-because-it-may-contain-foreign-material-6f8b4359</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/centricity-high-acuity-anesthesia-dda096db</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dxc-500i-clinical-analyzer-and-dxc-500-au-clinical-chemistry-analyzer-6a7d0b75</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/imn-screws-system-advanced-locking-screw-51e0eb9b</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-booming-business-on-wall-street-would-love-more-biotechs-to-quietly-die-9c672c38</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/draft-guideline-on-clinical-investigation-of-medicinal-products-for-the-treatmen-d0257213</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/epidural-kit-correction-medical-action-industries-issues-correction-for-epidural-f035b5c5</loc>
    <lastmod>2026-09-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/independent-commission-led-by-nhs-doctors-sets-out-blueprint-to-accelerate-safe--b628c2a1</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/research-national-commission-into-the-regulation-of-ai-in-healthcare-recommendat-fff2ab6f</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/human-drug-compounding-policies-and-rules-2f81220d</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/m3-r2-nonclinical-safety-studies-for-the-conduct-of-human-clinical-trials-and-ma-7fc72927</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tyra-disappoints-investors-with-bladder-cancer-data-547b6998</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kura-spins-diabetes-work-into-a-lilly-backed-biotech-startup-54de87d7</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-sevabertinib-for-locally-advanced-or-metastat-9a1109e1</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/patient-voice-in-rare-disease-medical-product-development-10-16-2026-cb550262</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-gains-continuity-as-mikhail-davis-named-permanent-cber-cder-leaders-72ace332</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-track-expanded-access-compassionate-use-submission-data-4eb8fa91</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-31-august-to-4-september-2026-a10ed14a</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/historical-status-of-otc-rulemakings-dec3aab5</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/veradius-unity-and-bv-pulsera-mobile-c-arm-system-9in-and-12in-versions-29364276</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/philips-ingenia-achieva-and-intera-mr-systems-0faff101</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/decision-advertising-investigations-august-2026-162dc12e</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/a-new-immuno-oncology-play-raises-225m-for-a-next-generation-drug-803b637c</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidelines-on-good-pharmacovigilance-practices-gvp-introductory-cover-note-last--f6f30114</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/six-ai-agents-one-deskside-system-a-new-model-for-clinical-decision-support-7140d519</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/freshpoint-issues-recall-due-to-an-improperly-declared-allergen-egg-in-chicken-s-49928d9e</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/summary-metrics-of-drug-development-tool-qualification-projects-submitted-to-fda-ed5d8a8f</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roivant-surges-on-exceptional-results-bristol-myers-touts-first-of-its-kind-car--bb9cc602</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/moonwalk-reloads-with-70m-and-new-rnai-prospects-for-obesity-44af189d</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-rna-drug-falls-short-in-rare-muscle-disease-study-5cf97a53</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/happy-farm-botanicals-inc-731926-09-01-2026-5e301623</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rare-diseases-at-fda-883f9ccb</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/brainchild-hauls-in-116m-to-make-cell-therapies-for-childhood-brain-cancers-bf9f66d0</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bmc-medical-co-ltd-recalls-luna-g3-apap-model-lg3600-with-firmware-g3-2-00-76-du-4e135715</loc>
    <lastmod>2026-09-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/co-ordinating-good-manufacturing-practice-gmp-inspections-for-centrally-authoris-8b094622</loc>
    <lastmod>2026-09-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/co-ordinating-good-manufacturing-practice-gmp-inspections-for-centrally-authoris-eb917fab</loc>
    <lastmod>2026-09-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/clinical-decision-support-system-exemption-amendments-517e5bb6</loc>
    <lastmod>2026-09-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/updated-classification-rules-for-certain-combination-products-5af027b3</loc>
    <lastmod>2026-09-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/made-fresh-salads-inc-recalls-ready-to-eat-deli-style-salads-and-cream-cheese-be-a66de814</loc>
    <lastmod>2026-09-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-ionis-drug-failure-spurs-questions-about-an-emerging-class-of-heart-med-1b23c323</loc>
    <lastmod>2026-09-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/temporary-policies-for-compounding-certain-starter-parenteral-nutrition-drug-pro-8ec9730b</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-takes-steps-to-maintain-newborn-access-to-life-saving-starter-nutrition-prod-2d5878ab</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-camizestrant-with-a-cdk4-6-inhibitor-for-esr1-ae3095a1</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-a-new-breast-cancer-treatment-6fa83a8a</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/zubb-dietary-supplement-may-be-harmful-due-to-hidden-ingredient-c46f8809</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/trailing-rivals-abbvie-scores-win-with-dual-acting-myeloma-drug-1343290f</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-china-deals-stock-flatlines-and-lilly-s-m-a-spree-abba2b3e</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/foods-alive-recalls-organic-moringa-leaf-powder-because-of-possible-health-risk-3b99d7a9</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gdufa-type-ii-api-dmf-payment-receipts-report-29a8ca52</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dental-technologies-inc-612599-09-02-2026-a4e7a735</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ionis-rare-neurology-drug-approved-pfizer-inks-an-adc-deal-bd14526f</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-31--50df47f2</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lifepak-35-monitor-defibrillator-5ef51dd6</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gore-viabahn-endoprosthesis-with-propaten-bioactive-58d04efa</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/imager-ii-angiographic-catheter-7cd506d7</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-eu-supply-chain-to-end-visudyne-shortage-3000848e</loc>
    <lastmod>2026-09-04</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/american-regent-inc-issues-voluntary-nationwide-recall-of-three-lots-of-epinephr-345af1a4</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-drug-to-treat-alexander-disease-b1a9df67</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/an-ai-drug-specialist-zeroes-in-on-rare-forms-of-obesity-1b1a816b</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/gsk-wagers-up-to-1-3b-on-a-different-kind-of-cancer-drug-0ed816b6</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fi-recalls-supplements-for-dogs-because-of-possible-salmonella-contamination-058b7cf8</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-drugs-to-prevent-and-treat-new-world--0bb7d32c</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ultragenyx-to-weigh-significant-cost-cuts-as-angelman-drug-fails-key-study-1f6ce9e4</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-24-to-28-august-2026-bfbddd31</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/phase-1-ind-chemistry-manufacturing-and-controls-flexibilities-dda4349b</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/phase-1-ind-procedures-and-policies-625ef1c6</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/akeso-summit-cancer-drug-confirms-lung-cancer-survival-benefit-115ebae7</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/supplx-com-issues-voluntary-nationwide-recall-of-business-pill-and-branch-manage-64b81ee8</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/botanical-drug-products-eeed1d2c</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tropical-disease-priority-review-voucher-program-f419809a</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-track-prescription-drug-user-fee-act-meeting-goals-summary-40011482</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-track-prescription-drug-user-fee-act-procedural-goals-summary-457daed8</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-seeks-public-input-to-advance-development-of-botanical-drug-products-94259f94</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-track-prescription-drug-user-fee-act-review-goals-summary-4356b4c8</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/what-is-a-botanical-drug-b598284f</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-update-on-estradiol-transdermal-patch-availability-bc24f725</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-hidden-scale-out-problem-behind-car-t-s-growth-933d4a65</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medicines-reclassify-your-product-9fe047ce</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eudravigilance-european-database-of-suspected-adverse-reactions-related-to-medic-8e46eb6d</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-breathing-circuit-issue-from-draeger-8615ce9f</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/monitoring-system-correction-ge-healthcare-updates-use-instructions-for-portrait-ad7957fe</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/spinal-cord-stimulator-recall-boston-scientific-removes-infinion-cx-lead-88ecc3f6</loc>
    <lastmod>2026-09-03</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/list-of-determinations-including-written-request-5e49f4ea</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/standard-safety-tables-and-figures-st-fs-25f7f447</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/office-of-new-drugs-custom-medical-queries-ocmqs-427e2016</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/good-clinical-practices-are-not-optional-the-fda-s-commitment-to-human-subject-p-ec6652dd</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/maxman-coffee-may-be-harmful-due-to-hidden-drug-ingredients-519de4e2</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-an-ee4003bb</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/autoimmune-car-t-faces-tough-questions-after-novartis-bristol-myers-study-halts-802496f7</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/uniqure-after-setbacks-seeks-fda-approval-of-huntington-s-gene-therapy-b06bdc66</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/frutas-y-hortalizas-del-sur-s-a-expands-recall-to-include-one-lot-of-great-value-251d1be5</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/teva-claims-success-in-celiac-study-biomarin-ascendis-settle-patent-dispute-6147a4e5</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bioresearch-monitoring-information-system-bmis-4e52b656</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-and-manchester-nhs-partner-on-health-innovation-sandbox-392d3264</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lifepak-35-monitor-defibrillator-ccdc49d5</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bicoag-hemostasis-probe-0469df4f</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/quantum-pureflow-standard-heat-exchanger-high-flow-ad380c76</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/leo-intracranial-self-expandable-stent-and-delivery-system-1a099fda</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/filters-should-be-used-during-the-administration-of-parenteral-nutrition-for-pat-1603138b</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/filters-should-be-used-during-the-administration-of-parenteral-nutrition-for-pat-cde7cd60</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-convenience-kits-contai-5d45f473</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-avid-medical-1d9fb9e5</loc>
    <lastmod>2026-09-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fdalabel-full-text-search-of-drug-product-labeling-278cd6b2</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-s-concerns-with-unapproved-glp-1-drugs-used-for-weight-loss-2beca337</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/safe-drug-use-after-a-natural-disaster-d26402c3</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-shortages-3955f868</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mid-cap-biotechs-join-trump-s-latest-round-of-drug-pricing-deals-7bf53bf3</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-says-ms-pill-succeeds-in-two-large-studies-0cb3b1e6</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/alumis-tyk2-drug-fails-in-key-lupus-study-d1ef1956</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-supply-chain-security-act-dscsa-97d3db32</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-safety-communications-72b1e051</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-adds-boxed-warning-to-labeling-for-ferric-carboxymaltose-injection-injectafe-11cbbdb6</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-proposes-framework-to-advance-credibility-of-ai-models-used-for-drug-and-bio-0186ae8e</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/preye-llc-732141-08-18-2026-e30c3114</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fresenius-medical-care-ag-co-kgaa-730319-08-25-2026-8f7e8d82</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/reliance-life-sciences-private-limited-730801-08-18-2026-1b54f006</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/jabil-inc-731037-08-27-2026-42cc326f</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/shoolin-pharma-chem-llp-734100-08-18-2026-46d1a58c</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-influenza-flu-vaccine-factsheet-information-for-patients-parents-and-ca-02c5b2f4</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/voluntary-data-submission-pilot-to-advance-innovative-alternatives-to-animal-tes-94b447d4</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-regulatory-reform-amendments-tabled-in-government-s-health-bill-6e465190</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-concludes-review-of-avacopan-vifor-following-reassessment-of-benefit-risk-b-b7d99ffa</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/breathing-circuit-recall-medline-removes-neonatal-and-infant-heated-wire-breathi-3bf1a395</loc>
    <lastmod>2026-09-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/novartis-bristol-myers-pause-autoimmune-car-t-trials-due-to-safety-concerns-43a8235e</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/international-collaboration-to-advance-new-testing-methods-that-reduce-reliance--578fcaaf</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/crystal-temptations-issues-allergy-alert-on-undeclared-milk-in-chocolatey-eyebal-28f562c3</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lmsi-llc-kofinas-olive-oil-issues-a-voluntary-recall-of-its-garlic-mediterranean-1cbe2a87</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-oks-takeda-protagonist-drug-for-rare-blood-cancer-7a63ae30</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medical-countermeasure-monitoring-and-assessment-23db3468</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lilly-adds-to-immune-drug-pipeline-with-2-9b-merida-buyout-956a4df8</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/esc-26-cytokinetics-sell-off-arrowhead-s-edge-and-a-heart-drug-autopsy-f987537a</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rare-disease-news-events-dfd9779a</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-treatment-for-essential-thrombocythemia-b3525b2b</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/jamp-temozolomide-out-of-specification-assay-eee1f871</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-next-frontier-advancing-foundation-models-with-multimodal-data-7644ba13</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ana-salazar-modela-tu-cuerpo-inc-issues-nationwide-voluntary-recall-of-lipofit-e-28dade07</loc>
    <lastmod>2026-08-31</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/northwest-naturals-voluntarily-recalls-two-raw-pet-food-products-because-of-poss-081dce13</loc>
    <lastmod>2026-08-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-drug-of-its-kind-for-polycythemia-vera-a-rare-blood-disorder-9a40bc62</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-stelara-for-pediatric-ulcerative-colitis-81b023f4</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/regulatory-education-for-industry-redi-annual-conference-2026-innovative-regulat-892132c1</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/partnership-for-dscsa-governance-pdg-fda-joint-public-meeting-dscsa-stabilizatio-a66ddba6</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mitigating-risks-from-human-xylazine-exposure-10-04-2023-cc340435</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-office-of-clinical-pharmacology-and-international-society-of-pharmacometrics-13c62033</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-cder-office-of-clinical-pharmacology-and-international-society-of-pharmacome-358109c5</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/advancing-the-use-of-complex-innovative-designs-in-clinical-trials-from-pilot-to-4111d04e</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/advances-in-pbpk-modeling-and-its-regulatory-utility-for-oral-drug-product-devel-0876b50f</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/2024-pda-fda-joint-regulatory-conference-09-09-2024-2caca0a6</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-to-request-a-labeler-code-b3ab0b5a</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/everything-sprouts-llc-expands-voluntarily-recall-to-include-robust-radish-mix-d-8bcf7980</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/12th-annual-global-summit-on-regulatory-science-10-19-2022-d8b150ac</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/panorama-produce-recalls-mangoes-due-to-possible-salmonella-contamination-31316b57</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/moderna-raises-2-6b-to-support-cancer-work-fda-clears-updated-covid-vaccines-31ddc4cc</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/astrazeneca-ionis-data-spark-debate-about-rna-drugs-impact-on-deadly-heart-disea-63de8c22</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/this-week-in-charts-biotech-s-rebound-is-undeniable-7d886b48</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-green-lights-priovant-drug-for-rare-skin-disease-2349c579</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/carestation-850-5f2a12e5</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-iv-start-kit-issue-from-avid-medical-072f3fe1</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-angiographic-catheter-issue-from-boston-scientific-a954ea1e</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/b-braun-medical-inc-issues-voluntary-nationwide-recall-of-0-9-sodium-chloride-in-f7a9e1b5</loc>
    <lastmod>2026-08-28</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-quality-center-of-excellence-instructor-led-trainings-6d4fe1b7</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-quality-center-of-excellence-self-guided-online-trainings-3d0f1ec7</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/search-list-of-extended-use-dates-to-assist-with-drug-shortages-ef4ebbdb</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-oral-drug-indicated-to-treat-dermatomyositis-in-adults-713ee912</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-generic-drug-to-prevent-new-world-scr-2569d911</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-risk-alerts-fb146565</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-reminds-compounders-not-to-use-dietary-supplement-grade-glutathione-for-inje-3654e34c</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/michael-polansky-has-a-new-skin-focused-biotech-don-t-call-it-a-drug-company-97b9dcd5</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-data-could-widen-use-of-astrazeneca-amgen-immune-disease-drug-4a6c8fbc</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/revolution-pancreatic-cancer-drug-should-quickly-become-a-blockbuster-analysts-s-097fe239</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/tga-approves-update-to-indication-for-truqap-capivasertib-1fbce589</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/apo-semaglutide-injection-incorrect-dose-display-24c21a80</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/automated-impella-controller-aic-18ebe1e7</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cardinal-health-gynaecology-robotics-and-endoscopy-packs-6114f389</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cari-anne-quinn-turning-possibility-into-progress-health-innovation-in-wales-ba9bec61</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/recommended-submission-dates-for-veterinary-medicinal-products-da7fa013</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-correction-avid-medical-issues-correction-for-kits-containing-me-52f9c922</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-esophageal-ph-monitoring-capsule-delivery-device-issue-from-medtroni-ad7d26f1</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/outsourcing-facilities-annual-study-67b1ebc7</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-quality-center-of-excellence-engage-with-the-compounding-quality-cen-7e846bd1</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/revolution-drug-heralded-as-a-pancreatic-cancer-breakthrough-cleared-by-fda-8bb24922</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/spyre-tumbles-as-immune-drug-misses-mark-in-rheumatoid-arthritis-68ae645d</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-daraxonrasib-for-metastatic-pancreatic-adenocarcinoma-a696ee63</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biohaven-trades-cash-for-upside-with-795m-epilepsy-drug-deal-5161dcce</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/exemptions-under-the-drug-supply-chain-security-act-842f97e2</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-in-class-targeted-therapy-for-metastatic-pancreatic-cancer-83ea3adf</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/south-africa-maintains-who-maturity-level-3-ml3-for-vaccine-regulation-b56e7f9e</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/zepbound-may-cut-healthcare-costs-study-says-summit-akeso-drug-hits-in-another-c-c0987bd2</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-documents-for-rare-disease-drug-development-95f48ed9</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/revival-animal-health-llc-voluntarily-recalls-feline-milk-replacers-due-to-incon-1cb65d63</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/increased-risk-of-wear-and-corrosion-identified-with-certain-cobalt-chrome-modul-6ab81c79</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cobalt-chrome-modular-neck-hip-replacements-risk-of-metal-wear-effects-and-revis-2d1da8a5</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/carescape-central-station-c126b590</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biofire-joint-infection-panel-30-pack-16ff81b3</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/med-rx-medication-primary-solution-administration-kit-d43f349f</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medicines-apply-for-a-parallel-import-licence-d64570af</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/baxter-issues-voluntary-nationwide-recall-for-two-lots-of-0-9-sodium-chloride-in-46fe4cdf</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/percutaneous-catheter-recall-boston-scientific-removes-enroute-transcarotid-neur-a02d365a</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-heart-pump-controller-purge-cassette-issue-from-abiomed-ff5c90c0</loc>
    <lastmod>2026-08-26</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-jazz-cancer-drug-approval-could-drive-blockbuster-sales-17e42d08</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/wap-sensual-enhancement-may-be-harmful-due-to-hidden-drug-ingredients-4b3a4fb9</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ongoing-non-malignant-hematological-neurological-and-other-disorder-indications--3029c97e</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-drug-to-treat-hiv-infection-in-newborns-cbdda93b</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ongoing-infectious-disease-accelerated-approvals-excluding-vaccines-75561ff6</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/accelerated-approval-program-3d41cfbd</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ectd-submission-standards-for-ectd-v3-2-2-and-regional-m1-545d8889</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-drug-for-warm-autoimmune-hemolytic-anemia-98753347</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-authorizes-first-wearable-device-that-continuously-monitors-both-ketone-leve-1733cd22</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-eli-lilly-get-fda-nod-for-new-alzheimer-s-blood-test-3409ef6a</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/c3ti-compass-knowledge-repository-7cb4ab14</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/human-drug-compounding-outsourcing-facility-fees-08c7e3ec</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-shortages-additional-news-and-information-a1813ade</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/qu-feng-huo-lou-dan-may-be-harmful-due-to-hidden-ingredient-918e7b1e</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/jaime-s-foods-atx-issues-allergy-alert-on-undeclared-egg-allergen-in-jaime-s-spa-08659199</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-safety-roundup-august-2026-b35e2b02</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dr-ger-ventstar-resus-neo-and-ventstar-resuscitaire-01d3277f</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/twins-herbal-products-undeclared-prescription-drug-sildenafil-e3ba28ac</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/will-a-reset-reignite-investment-in-women-s-health-startups-baef3791</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/standard-category-lists-following-implementation-of-the-windsor-framework-e03345d4</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/young-startups-miss-out-on-biotech-venture-funding-rebound-massbio-says-52416a64</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/baxter-issues-voluntary-nationwide-recall-for-one-lot-of-70-dextrose-injection-d-d125626b</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/baxter-issues-voluntary-nationwide-recall-for-one-lot-of-anticoagulant-sodium-ci-16194cb5</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-better-bakehouse-snack-company-is-recalling-certain-lots-of-donutful-chocola-6749453c</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rare-disease-drug-approvals-e006e36d</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/content-and-format-of-the-rdea-meeting-request-and-package-rare-disease-endpoint-8ac9e6ee</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ways-for-consumers-to-contact-fda-about-human-drugs-ddfa5a07</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/counterfeit-medicine-a4826a4b</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/drug-supply-chain-integrity-1b87cbeb</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-drug-supply-chain-security-act-dscsa-waivers-exceptions-and-exemptions-a3d32f1c</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/illegally-sold-monkeypox-mpox-products-6bac9571</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/umary-and-related-products-66b7d170</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pdufa-vii-information-technology-and-bioinformatics-goals-and-progress-fbd33a79</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cder-small-business-and-industry-assistance-sbia-learn-08507716</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/navigating-the-fda-bayesian-draft-guidance-design-analysis-and-review-considerat-9d59627b</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/safety-concerns-spur-fda-to-again-halt-testing-of-regenxbio-gene-therapy-fb889a9c</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-extends-review-of-capricor-cell-therapy-pain-drug-startup-to-go-public-66c3db3d</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cellares-a-cell-therapy-manufacturing-specialist-to-lay-off-100-employees-d7c65c0b</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/roche-commits-to-lean-mass-preservation-with-hanmi-obesity-deal-66c688bb</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ngpod-ph-testing-device-quarantine-and-dispose-of-all-devices-dsi-2026-009-21834fcb</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-17-to-21-august-2026-f1a18b39</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/importation-of-south-korean-authorized-bonky-injection-1-mcg-ml-calcitriol-due-t-70ae5e28</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pharma-marketers-need-a-share-of-answer-strategy-before-ai-spend-0d657a90</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-nitric-oxide-delivery-system-issue-from-noxbox-651c8487</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/vitruvias-therapeutics-inc-issues-nationwide-recall-of-one-lot-of-thyroid-tablet-7b574c07</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-avid-medical-162517b0</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-ventilator-issue-from-coopersurgical-6d19ef47</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-medline-c8f3f978</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/everything-sprouts-llc-recalls-alfalfa-sprouts-due-to-potential-e-coli-and-salmo-2820a64b</loc>
    <lastmod>2026-08-22</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fromm-family-foods-voluntarily-recalls-turkey-p-t-wet-food-for-dogs-and-diner-cl-bfd21e6e</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/40th-anniversary-of-the-generic-drug-approval-pathway-1f6135df</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-and-the-fda-questions-and-answers-16c60197</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/generic-drugs-questions-answers-e4b67a00</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/compounding-information-for-states-575ff353</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/rulemaking-history-for-otc-sunscreen-drug-products-6dc7833b</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/generic-drugs-103f91cd</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/science-research-1e205096</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/complex-generics-news-9cd914c3</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/what-is-the-approval-process-for-generic-drugs-8186c959</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/industry-resources-9910fe9f</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/approvals-reports-535ee536</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public--3a924402</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biosimilar-and-interchangeable-biosimilar-products-considerations-for-container--f9fe2411</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-guidance-on-pharmacovigilance-procedures-c4ac5452</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/shareholder-pressures-capricor-lilly-dives-deeper-into-vaccines-7302ac66</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-publishes-new-product-specific-guidances-to-facilitate-generic-drug-developm-4badfd2f</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/evaluation-of-therapeutic-equivalence-5fe3f114</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/aisys-cs-and-carestation-32567351</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/iq200-series-analyzers-and-dxu-840m-850m-iris-analyzers-8b70a876</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/foresight-oximeter-cable-0c5d37d7</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/how-cost-and-perception-could-reshape-the-glp-1-market-6d1104f6</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-epidural-kit-issue-from-medical-action-industries-50680f15</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-portrait-core-services-software-issue-from-ge-healthcare-b224215e</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-breathing-circuit-issue-from-medline-2b39a3ac</loc>
    <lastmod>2026-08-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-south-african-health-products-regulatory-authority-reaffirms-the-safety-of-r-ca6da42c</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/regeneron-to-challenge-ipsen-as-fda-clears-bone-disease-drug-b3130524</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cancer-vaccine-win-restores-wall-street-s-faith-in-moderna-644bcc1d</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ultragenyx-after-setbacks-nabs-first-gene-therapy-approval-ca08aca0</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/class-2-medicines-recall-zentiva-pharma-uk-limited-fingolimod-zentiva-0-5-mg-cap-99334aa8</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-and-template-for-industry-on-implementing-shortage-prevention-plans-spp-3fe5308f</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/centricity-enterprise-archive-and-pacs-workstation-ff8cc37d</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/theragun-pro-333f6890</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/patient-information-centre-ix-5bfc2200</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-recall-medline-issues-correction-for-convenience-kits-containing-81d29fe8</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/optimal-balance-pharmacy-issues-voluntary-nationwide-recall-of-certain-lots-of-c-616e001b</loc>
    <lastmod>2026-08-20</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-first-therapy-for-patients-aged-8-years-and-older-with-glycogen-sto-2043333b</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prince-bakery-inc-issues-allergy-alert-on-undeclared-milk-and-sesame-in-prince-b-a69abba9</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/postmarketing-requirements-and-commitments-reports-ea08f158</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/angiotensin-converting-enzyme-inhibitor-induced-angioedema-risk-of-serious-and-f-98bd10ad</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/patient-listening-session-summaries-3e96bcb3</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-authorizes-first-of-its-kind-robotic-blood-draw-device-e51d7664</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-approves-second-treatment-for-fibrodysplasia-ossificans-progressiva-bb105cb5</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/trump-reportedly-plans-to-tap-policy-aide-overton-to-lead-fda-3bd521ff</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/generic-drug-research-related-guidances-reports-24279ac9</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/completed-pdufa-vii-deliverables-66f133f0</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/moderna-and-merck-cancer-vaccine-returns-landmark-result-in-melanoma-b5f0dceb</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/spectralis-with-flex-module-5ff5ca14</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/embosphere-microspheres-syringe-0e890201</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/statstrip-glucose-and-beta-ketone-hospital-meter-b763468c</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ema-procedural-advice-for-medicinal-products-intended-exclusively-for-markets-ou-5a6b2e59</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/b-braun-medical-inc-issues-voluntary-north-american-recall-of-excel-lactated-rin-fdbd9db3</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/updated-dreyer-s-grand-ice-cream-inc-issues-voluntary-recall-on-select-outshine--cf18a57e</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/partner-with-us-to-help-more-providers-prescribe-with-confidence-2188874c</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/antiseptic-fda-letters-710a4cc0</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/antiseptic-meetings-35d9d549</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/topical-antiseptic-drug-products-dd2a4c9a</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/esbelta-intense-loss-may-be-harmful-due-to-hidden-ingredients-00c5d9b0</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/esbelta-chupapanza-flat-belly-may-be-harmful-due-to-hidden-ingredient-ad5ae568</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/orange-book-data-files-1911e066</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prescription-drug-user-fee-amendments-02954528</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biomarin-acquires-experimental-drug-for-rare-bone-disorder-in-275m-deal-1e3468ec</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/astrazeneca-scores-in-lung-cancer-sandoz-inks-a-china-deal-5dbeb6f9</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/leo-pharma-buys-rare-skin-disease-drug-in-435m-deal-b8856c2e</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/frequently-requested-or-proactively-posted-compliance-records-7a642e70</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eugia-pharma-specialities-limited-730469-08-13-2026-0eb9bf10</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/k-c-pharmaceuticals-inc-729870-08-12-2026-637ef878</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/suretec-innovations-llc-730122-08-13-2026-fba133b2</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/auriga-research-pvt-ltd-730694-08-12-2026-c1d7630c</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/safrel-pharmaceuticals-llc-730520-08-07-2026-e696b334</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-advises-against-the-use-of-rectal-catheters-in-infants-0e45be3f</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/all-rectal-catheters-gas-and-colic-relievers-do-not-use-in-infants-including-for-e44c9734</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/unauthorized-drugs-seized-from-rabais-4saisons-inc-in-montreal-qc-may-pose-serio-227d76fa</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/field-safety-notices-10-to-14-august-2026-8a1c8ffc</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/amylyx-s-bet-on-a-glp-1-blocker-pays-off-190c2612</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-sets-out-position-on-regulation-of-microbiome-based-medicinal-products-49abf9a0</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/policy-paper-uk-position-paper-on-microbiome-based-medicinal-products-mbmps-5fc54077</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-becton-dickinson-562f7525</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/l-nutra-issues-allergy-alert-on-undeclared-tree-nuts-in-prolon-brand-apulian-alm-2716a902</loc>
    <lastmod>2026-08-18</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/updated-oma-s-pride-voluntarily-recalls-one-lot-of-woof-complete-canine-chicken--6162aa1b</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-public-meeting-fda-led-patient-focused-drug-development-meeting-for-nonheali-136949be</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-drug-competition-action-plan-improving-the-efficiency-of-the-generic-drug-de-a9175a3f</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-drug-competition-action-plan-08c25fba</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/determining-whether-to-submit-an-anda-or-a-505-b-2-application-07e5dee0</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/argenx-jumps-on-phase-3-data-for-blockbuster-vyvgart-7175e898</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/eyepoint-plummets-on-pivotal-data-for-main-drug-a730de2d</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/astrazeneca-scraps-phase-3-trial-of-new-bispecific-in-lung-cancer-4f47fedd</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/determining-whether-to-submit-an-anda-or-a-505-b-2-application-243fb1a1</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/slate-fulcrum-to-combine-in-reverse-merger-09c8c3d1</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-nod-is-just-the-first-hurdle-for-moderna-s-potential-blockbuster-flu-vax-dac5a6d5</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-consultation-on-statutory-fees-2026-72276829</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/cook-medical-hemospray-kit-a38caa53</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lactated-ringer-s-injection-usp-presence-of-particulate-matter-be7516dd</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/national-patient-safety-alert-resmed-astral-100-and-150-ventilators-potential-fo-ef9d38a1</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/guidance-clinical-trials-phase-1-14-day-pilot-programme-f652f4be</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sahpra-inspires-tut-students-to-pursue-careers-in-health-regulation-b86ca4c7</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/intraosseous-needle-set-recall-becton-dickinson-removes-certain-intraosseous-vas-4b921d0e</loc>
    <lastmod>2026-08-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/sahpra-recalls-certain-batches-of-enalapril-10-mg-used-to-treat-high-blood-press-68139bae</loc>
    <lastmod>2026-08-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/two-lots-of-teva-pregabalin-150-mg-capsules-recalled-due-to-cross-contamination--6151cc42</loc>
    <lastmod>2026-08-15</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-hampton-grocers-inc-recalls-it-s-8-ounce-packages-of-lacnola-lactation-grano-076f9578</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/addressing-the-public-health-effects-of-opioid-medications-09-09-2026-1d1b674d</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/exotique-foods-inc-recalls-momchipz-veggie-chips-broccoli-florets-cauliflower-du-f276fed5</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/the-center-for-research-on-complex-generics-315ac7c5</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-center-for-research-on-complex-generics-crcg-workshop-on-advancing-bioequiva-66f35478</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/bristol-myers-wins-milestone-fda-approval-of-myeloma-drug-acquired-from-celgene-a95d240e</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/withdrawn-cancer-accelerated-approvals-cb671d66</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/container-closure-systems-for-human-drugs-and-biological-products-11d2976f</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/public-meeting-on-the-recommendations-for-reauthorization-of-the-prescription-dr-634bcd42</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/capricor-shares-spike-on-ceo-comments-cytokinetics-sues-bristol-myers-a91a4d39</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/endotracheal-tube-cuffed-c355a492</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/orthopaedic-implant-components-a9bf23fa</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/vimseltinib-romvimza-approved-for-use-in-adults-to-treat-tenosynovial-giant-cell-2a24fdf1</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/biotech-initiatives-pick-up-as-more-regions-race-to-become-hubs-fba058b6</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medicines-get-scientific-advice-from-the-mhra-e0d2538f</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/completed-bsufa-iii-deliverables-ff6e1175</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-grants-accelerated-approval-to-iberdomide-with-daratumumab-and-hyaluronidase-169c4331</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/updated-grand-central-bakery-seattle-recalls-potato-sourdough-bread-due-to-possi-f38401b5</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/grand-central-bakery-recalls-potato-sourdough-bread-due-to-possible-foreign-obje-4276e78e</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/medical-products-for-rare-diseases-and-conditions-b9ae9b36</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/small-business-assistance-f49f4e0b</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/phase-1-investigational-new-drug-ind-navigator-0f5896d3</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/upcoming-el-pfdd-meetings-2ba5aadc</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/condition-specific-meeting-reports-and-other-information-related-to-patients-exp-fc03be99</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/fda-issues-emergency-use-authorization-for-drug-to-treat-new-world-screwworm-in--dfbb1dce</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/new-taiho-cullian-data-heats-up-lung-cancer-drug-battle-ab832b1a</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/ptc-takes-a-chance-on-sangamo-s-fabry-disease-gene-therapy-5744a11a</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/information-regarding-insulin-storage-and-switching-between-products-in-an-emerg-5a3e5f26</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/laboratory-information-bulletins-53fc7f58</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/nitrosamine-impurities-acceptable-intake-update-6511aa19</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/covid-19-test-approval-how-to-apply-52195636</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/you-ve-got-the-grades-but-don-t-pass-on-your-health-cd30f716</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/corporate-report-mhra-quarterly-results-and-forecast-2026-to-2027-42e32bcd</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/portrait-core-services-cssxb-9b5d4e63</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/iv-tubing-set-drip-chambers-010e54e2</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/intravascular-administration-set-recall-baxter-removes-duo-vent-solution-sets-6f309de8</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/oma-s-pride-voluntarily-recalls-one-lot-of-woof-complete-canine-chicken-recipe-6-fcb39b3d</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/kettle-cuisine-recalls-marketside-tomato-bisque-soup-kit-sold-exclusively-at-wal-6a2e5901</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prescription-to-nonprescription-switch-list-drugs-cffd05be</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/anaconda-premium-500k-may-be-harmful-due-to-hidden-ingredient-0e5890bf</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/premium-orgazen-10000-may-be-harmful-due-to-hidden-ingredient-8f7dbf85</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/hardie-s-fresh-foods-recalls-jalapenos-because-of-possible-health-risk-e021cb9f</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prescription-to-nonprescription-rx-to-otc-switches-932a3b4f</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/prescription-to-nonprescription-switch-list-c86024bd</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/whole-foods-market-announces-a-recall-of-select-salsas-guacamole-pico-de-gallo-a-b19619bd</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/weight-loss-product-notifications-1c3962c5</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/b-magi-may-be-harmful-due-to-hidden-ingredients-4611b8cf</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/dmagic-plus-may-be-harmful-due-to-hidden-ingredients-5953985e</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lilly-files-six-lawsuits-in-bid-to-shut-down-black-market-for-retatrutide-b7a2d10f</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/activities-report-of-the-generic-drug-program-fdara-title-viii-sections-807-and--ffa142a1</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/q3c-r8-impurities-guidance-for-residual-solvents-3576e3bd</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/psychedelics-developer-definium-scores-more-positive-data-for-lsd-pill-7c80ad5c</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/consultation-on-improving-the-sharing-of-information-about-medical-devices-85f136ff</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/non-compliance-letters-under-505b-d-1-of-the-federal-food-drug-and-cosmetic-act-39c0c77c</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/assessment-of-the-use-of-patient-experience-data-in-regulatory-decision-making-d51274ef</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/table-of-pharmacogenomic-biomarkers-in-drug-labeling-88eb9e8f</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/silence-cashes-in-on-differentiated-data-uk-reaffirms-support-for-childhood-vacc-b09378b9</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products-3110efdf</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/unauthorized-injectable-health-products-sold-online-and-seized-from-dyosa-beauty-92da32c5</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/pms-irbesartan-affected-lot-may-contain-pms-irbesartan-hctz-150-12-5-mg-tablets-024402e8</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/mhra-reaffirms-the-safety-of-childhood-vaccination-168ea091</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/boulevard-starts-up-with-65m-to-pursue-targeted-autoimmune-drugs-100ae3a6</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-cedbe959</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-f0c7c0ac</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/update-on-alert-convenience-kit-issue-from-medline-e25acf49</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-convenience-kits-contai-bee0fb11</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/recall-of-jalapeno-avocado-dressing-because-of-possible-health-risk-9eaa91c6</loc>
    <lastmod>2026-08-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://platform.ontopharmatech.com/news/lidl-us-recalls-vitasia-asian-style-wok-spice-mix-due-to-potential-salmonella-co-c9d31f3b</loc>
    <lastmod>2026-08-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
</urlset>